# EX VIVO CLINICAL TRIAL
Valbiotis annonce les résultats positifs de l’étude clinique de biodisponibilité et de mode d’action de TOTUM•070 contre l’hypercholestérolémie

https://www.ahajournals.org/doi/abs/10.1161/circ.146.suppl_1.11397?af=R

This clinical innovative approach provides robust human data regarding the health benefits of a product in faster, more affordable and more mechanistic ways (mode of action in humans) than any conventional clinical trial. Using human metabolites (circulating and bioavailable bioactives) this approach is more physiological than any in vitro test. The approach is also intended to be ethical since it allow to get rid of an animal experimentation. #clinicncell #clinic’n’cell

AND ONE MORE PUBLICATION… FOR CLINICNCELL = NOW 6 INTERNATIONAL PEER REVIEWED MANUSCRITS AND ONGOING

https://pubmed.ncbi.nlm.nih.gov/36501057/

Nutrients 2022 Nov 25;14(23):5027. doi: 10.3390/nu14235027

Benefits of Circulating Human Metabolites from Fish Cartilage Hydrolysate on Primary Human Dermal Fibroblasts, an Ex Vivo Clinical Investigation for Skin Health Applications.

Fabien Wauquier 1, Line Boutin-Wittrant 1, Elodie Bouvret 2, Julie Le Faouder 2, Véronique Roux 3, Nicolas Macian 3, Gisèle Pickering 3, Yohann Wittrant 4 5

ClinicnCell

🍾 🏆 🥇🔬CLINIC’N’CELL SAS has just obtained the renewal of its CIR approval for 2023 – 2024 and 2025. A great recognition from the General Direction of Research and Innovation of the French Ministry of Higher Education and Research

This clinical innovation provides robust human data regarding the health benefits of a product in faster, more affordable and more mechanistic ways (mode of action in humans) than any conventional clinical trial. Using human metabolites (circulating and bioavailable bioactives) this approach is more physiological than any in vitro test. The approach is also intended to be ethical since it allow to get rid of an animal experimentation. #clinicncell #clinic’n’cell